High unmet medical need for therapies that can reduce the substantial treatment burden affecting millions of patients globallyCombined in-licensing and ...

New Mountain Capital, LLC ("New Mountain"), a leading growth-oriented investment firm with more than $55 billion in assets under management, today announced a definitive agreement to acquire Machinify ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that Chief Executive Officer Vlad Vitoc, M ...